What is the current Stratec market capitalization?
The current market capitalization of Stratec is 486.35 M EUR.
Stratec Market capitalization 2024
Stratec Market capitalization
486.35 M EUR
Ticker
SBS.DE
ISIN
DE000STRA555
WKN
STRA55
In 2024, Stratec's market cap stood at 486.35 M EUR, a -13.48% increase from the 562.1 M EUR market cap in the previous year.
The Stratec Market capitalization history
| YEAR | Market Capitalization (undefined EUR) |
|---|---|
| 2023 | 0.71 |
| 2022 | 1.17 |
| 2021 | 1.52 |
| 2020 | 1.13 |
| 2019 | 0.76 |
| 2018 | 0.8 |
| 2017 | 0.67 |
| 2016 | 0.6 |
| 2015 | 0.58 |
| 2014 | 0.45 |
| 2013 | 0.39 |
| 2012 | 0.38 |
| 2011 | 0.35 |
| 2010 | 0.33 |
| 2009 | 0.2 |
| 2008 | 0.18 |
| 2007 | 0.26 |
| 2006 | 0.2 |
| 2005 | 0.11 |
| 2004 | 0.04 |
Stratec Aktienanalyse
What does Stratec do?
The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Stratec's Market Capitalization
Stratec's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Stratec's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Stratec's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Stratec’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Stratec stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Stratec.
How has the market capitalization of Stratec developed in recent years?
The market capitalization of Stratec has increased/decreased by -13.48% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Stratec?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Stratec?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Stratec have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Stratec pay?
Over the past 12 months, Stratec paid a dividend of 0.97 EUR . This corresponds to a dividend yield of about 2.43 %. For the coming 12 months, Stratec is expected to pay a dividend of 1.05 EUR.
What is the dividend yield of Stratec?
The current dividend yield of Stratec is 2.43 %.
When does Stratec pay dividends?
Stratec pays a quarterly dividend. This is distributed in the months of June, June, June, June.
How secure is the dividend of Stratec?
Stratec paid dividends every year for the past 0 years.
What is the dividend of Stratec?
For the upcoming 12 months, dividends amounting to 1.05 EUR are expected. This corresponds to a dividend yield of 2.62 %.
In which sector is Stratec located?
Stratec is assigned to the 'Health' sector.
Wann musste ich die Aktien von Stratec kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Stratec from 5/22/2024 amounting to 0.55 EUR, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.
When did Stratec pay the last dividend?
The last dividend was paid out on 5/22/2024.
What was the dividend of Stratec in the year 2023?
In the year 2023, Stratec distributed 0.95 EUR as dividends.
In which currency does Stratec pay out the dividend?
The dividends of Stratec are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Stratec stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Stratec
Our stock analysis for Stratec Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stratec Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
